These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8842069)

  • 1. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for mortality in patients with insulin-dependent diabetes].
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    Ugeskr Laeger; 1998 Feb; 160(9):1315-9. PubMed ID: 9495080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
    Gall MA; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
    Forsblom CM; Groop PH; Ekstrand A; Groop LC
    BMJ; 1992 Oct; 305(6861):1051-3. PubMed ID: 1467683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus.
    Rossing P; Breum L; Major-Pedersen A; Sato A; Winding H; Pietersen A; Kastrup J; Parving HH
    Diabet Med; 2001 Mar; 18(3):199-205. PubMed ID: 11318840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study.
    Rossing P; Hougaard P; Parving HH
    Diabetes Care; 2002 May; 25(5):859-64. PubMed ID: 11978681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.
    Jansson FJ; Forsblom C; Harjutsalo V; Thorn LM; Wadén J; Elonen N; Ahola AJ; Saraheimo M; Groop PH;
    Diabetologia; 2018 May; 61(5):1203-1211. PubMed ID: 29423580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microalbuminuria in diabetes mellitus--illness or symptom?].
    Müller WA
    Versicherungsmedizin; 1996 Jun; 48(3):70-6. PubMed ID: 8737541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
    Mathiesen ER; Hommel E; Giese J; Parving HH
    BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of microalbuminuria in IDDM. A five-year follow-up study.
    Almdal T; Nörgaard K; Feldt-Rasmussen B; Deckert T
    Diabetes Care; 1994 Feb; 17(2):120-5. PubMed ID: 8137681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status.
    Parente EB; Harjutsalo V; Lehto M; Forsblom C; Sandholm N; Groop PH;
    Cardiovasc Diabetol; 2020 May; 19(1):68. PubMed ID: 32429911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study.
    Mathiesen ER; Rønn B; Storm B; Foght H; Deckert T
    Diabet Med; 1995 Jun; 12(6):482-7. PubMed ID: 7648820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria and mortality in long-duration type 1 diabetes.
    Allen KV; Walker JD
    Diabetes Care; 2003 Aug; 26(8):2389-91. PubMed ID: 12882867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significant risk factors for development of microalbuminuria and diabetic nephropathy in patients with non-insulin-dependent diabetes].
    Gall ML; Hougaard P; Borch-Johnsen K; Parving HH
    Ugeskr Laeger; 1998 Jul; 160(31):4524-7. PubMed ID: 9700308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Na+/Li+ countertransport activity may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria.
    Chiarelli F; Catino M; Tumini S; de Martino M; Mezzetti A; Verrotti A; Vanelli M
    Diabetes Care; 1999 Jul; 22(7):1158-64. PubMed ID: 10388982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.
    Hovind P; Tarnow L; Rossing P; Jensen BR; Graae M; Torp I; Binder C; Parving HH
    BMJ; 2004 May; 328(7448):1105. PubMed ID: 15096438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of persistent microalbuminuria in patients with diabetes mellitus.
    Bach LA; Gilbert RE; Cooper ME; Tsalamandris C; Jerums G
    J Diabetes Complications; 1993; 7(2):67-72. PubMed ID: 8518458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.
    Valmadrid CT; Klein R; Moss SE; Klein BE
    Arch Intern Med; 2000 Apr; 160(8):1093-100. PubMed ID: 10789601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.